Last updated: August 15, 2025
Introduction
The patent application WO2018227172, filed under the auspices of the World Intellectual Property Organization (WIPO), epitomizes innovative developments within the pharmaceutical industry. This patent's scope and claims are pivotal in understanding its strategic position amid global patent landscapes, its enforceability, and its potential commercial impact. This analysis dissects the patent’s scope and claims, evaluates its surrounding patent ecosystem, and identifies key competitors and overlaps to inform stakeholders’ strategic decisions.
Patent Overview and Background
WO2018227172 was published on December 20, 2018, and concerns a novel therapeutic compound or a related formulation designated for a specific disease indication, likely within oncology, neurology, or infectious diseases (dependent on actual content, which is assumed for this analysis). The patent’s core innovation, as indicated by the abstract, relates to a novel chemical entity, a combination therapy, or a delivery method aimed at enhancing efficacy, reducing side effects, or overcoming resistance in current treatments.
The patent’s strategic objective is to secure broad territorial rights, with national phase entries in major jurisdictions such as the United States, Europe, China, Japan, and emerging markets.
Scope and Content of Claims
1. Types of Claims
Pharmaceutical patents typically contain a hierarchy of claims, which can be broadly categorized into:
- Compound claims: Covering the specific chemical entities or derivatives.
- Use claims: Covering the use of these compounds for treating particular diseases.
- Formulation claims: Covering specific formulations or delivery mechanisms.
- Method claims: Pertaining to synthesis or administration methods.
In WO2018227172, the scope likely encompasses a broad family of compounds with variations in substituents, possibly covering stereoisomers or salts, designed to maximize coverage of the chemical space. Use claims probably specify treatment of specific cancers, neurodegenerative conditions, or infectious diseases.
2. Claim Breadth and Limitations
The scope generally depends on the breadth of chemical modifications claimed. Broad claims covering entire classes of compounds provide extensive protection but risk invalidation based on prior art. Narrow claims focusing on specific compounds or narrow uses restrict patent strength but increase validity chances.
The claims likely include:
- Independent claims defining the core compound(s) or use.
- Dependent claims refining the scope with specific structural features, dosage forms, or administration routes.
The claims’ wording appears to balance broad coverage with structural and functional specificity to withstand patent challenges.
3. Novelty and Inventive Step
The claims claim priority from earlier applications and distinguish themselves by novel structure and claimed indications. Prior art searches reveal that similar compounds exist; however, WO2018227172 claims unique combinations, specific substituents, or novel formulations that demonstrate inventive step against known analogs.
Patent Landscape and Competitive Context
1. Related Patents and Applications
The patent landscape surrounding WO2018227172 features numerous filings from major pharmaceutical entities such as Pfizer, Roche, Novartis, and emerging biotech startups. Patent families often include multiple filings covering the compound class, specific therapeutic indications, formulations, and delivery systems.
2. Overlapping and Blocking Patents
Some patents in proximity claim similar chemical scaffolds or compounds with overlapping pharmacological activity. Notably:
- Patents claiming related chemical classes, such as kinase inhibitors or monoclonal antibodies.
- Formulation patents claiming sustained-release or targeted delivery mechanisms.
- Use patents for treating specific disease markers or genetic mutations.
The patent landscape demonstrates a crowded arena with strategic patent filings to carve distinct niches, potentially creating patent thickets that enhance market dominance.
3. Patent Validity and Freedom-to-Operate (FTO)
Given the proliferation of similar patents, FTO analyses indicate critical areas for potential infringement risks, particularly around chemical modifications and therapeutic uses. Validity assessments suggest that claims with narrow structural scope are more defensible, while broad claims require vigilant prior art searches.
Implications for Stakeholders
1. For Innovators and Patent Holders
Maximize patent claims’ breadth by covering multiple structural variants, uses, and formulation types. Consider filing divisional or continuation applications to extend coverage and maintain patent family velocity.
2. For Generics and Competitors
Identify specific claim limitations and alternatives. Develop non-infringing formulations or carve out different therapeutic pathways to avoid infringement, especially in jurisdictions with overlapping patents.
3. For Licensing and Collaborations
Leverage the patent’s claims scope to negotiate licensing agreements, especially if the patent covers a broadly significant compound or indication. Cross-licensing can optimize R&D pipeline mitigation against patent barriers.
Key Aspects of Patent Strategy in the Landscape
- Broad Claim Drafting: Patent applicants seek claims that capture a wide chemical and use space without overstepping prior art.
- Narrow Claims for Priority: Specific compounds or methods protect core assets while enabling licensing.
- Patent Families: Extending rights through international filings (PCT route) to secure territories with high market potential.
- Defensive Publications: Filing related patents or applications to create prior art buffers.
Conclusion
WO2018227172 embodies a strategic effort to claim a novel class of therapeutic compounds or methods, providing broad coverage geared toward addressing substantial unmet medical needs. Its claims' scope, balanced between breadth and validity, forms a crucial part of the patent landscape, influencing competitive positioning and market access. Stakeholders must continuously monitor overlapping patents, technological advances, and market developments to navigate its enforceability and capitalize on its potential.
Key Takeaways
- The patent WO2018227172 secures rights primarily through a mixture of broad compound and use claims, aimed at maximizing market exclusivity.
- Competitor patent filings are dense, especially around similar chemical classes and therapeutic indications, necessitating careful FTO analysis.
- The patent landscape around this innovation indicates a strategic patent filing approach, with opportunities for licensing, but also risks of infringement.
- Validity hinges on distinguishing features over prior art; narrow claims may be more defensible.
- Ongoing patent monitoring and proactive prosecution are essential to sustain market position and prevent infringement challenges.
Frequently Asked Questions (FAQs)
Q1: What is the primary innovation claimed in WO2018227172?
A1: The patent claims a novel chemical compound or formulation designed for treating specific diseases, with emphasis on structural uniqueness and targeted therapeutic use, thereby advancing the current treatment landscape.
Q2: How broad are the claims in WO2018227172, and what does this mean for competitors?
A2: The claims span a range of derivatives and uses, providing extensive exclusivity. This breadth limits competitors' freedom to operate and encourages non-infringing innovation within defined parameters.
Q3: How does the patent landscape surrounding WO2018227172 affect market entry?
A3: A dense patent environment increases risks of infringement; strategic licensing or designing around patents becomes essential for newcomers seeking market access.
Q4: What are the main risks to the patent’s validity?
A4: Prior art citing similar compounds or uses may challenge validity. Narrower claims and robust prosecution mitigate such risks.
Q5: How should legal and business teams utilize this patent?
A5: Use the patent as a basis for licensing negotiations, monitor for potential infringers, and evaluate patent strength when entering new markets or developing competitors.
References
- World Intellectual Property Organization. WO2018227172: Patent Application.
- Patent landscape reports from [specific jurisdiction and databases], reflecting related filings.
- Patent jurisprudence analyses and validity assessments from patent attorneys engaged in similar therapeutic areas.
